Samsung Electronics announced that the irregular heart rhythm notification feature of its health monitor app received FDA clearance. Combined with the app’s existing on-demand ECG function, the feature proactively monitors heart rhythms suggestive of AFib. It all works straight from the user’s wrist through the Samsung Galaxy Watch. “We’re excited to announce that irregular heart […]
Samsung Electronics Co. Ltd.
FDA clears mobile CT scanner from Samsung’s NeuroLogica
NeuroLogica — a Samsung Electronics subsidiary — announced today that it received FDA 510(k) clearance for its next-gen BodyTom 64 scanner. Danvers, Massachusetts-based NeuroLogica designed its BodyTom 64 for point-of-care mobile computed tomography (CT). BodyTom 64 offers revisions to the company’s software and data acquisition system (DAS) based on customer feedback. For example, NeuroLogica incorporated […]
Samsung wins FDA nod for next-gen RS85A ultrasound
Samsung Electronics (LON:BC94) subsidiary Samsung NeuroLogica said today it won FDA 510(k) clearance for its RS85A ultrasound device. The RS85A system features new Samsung technology including the MV-Flow feature which allows for the visualization of slow-flow micro vascularized structures and S-Shearwave Imaging technology which quantifies the elasticity of tissue or lesions. The newly cleared system also […]
Your fitness tracker could be misleading you
Your heart rate may be accurate on your fitness tracker, but the number of calories burned is significantly wrong, according to new research from Stanford University. The researchers suggest that although the heart rate measurements are pretty much accurate, energy expenditure measurements are probably significantly wrong. Apple Watch, Basis Peak, Fitbit Surge, Microsoft Band, Mio […]
How virtual and mixed reality are changing drug delivery and device design
Kai Worrell believes that virtual and mixed reality may change the way companies design medical devices, and he’s putting that idea into practice. “We think it’s going to transform the way we do feasibility testing and cognitive walk-through simulations,” he said. “We think it’s going to help us understand the cognition of our users, clinical […]
Samsung Biologics IPO could reach $2B, company value above $8B
Biotech drug contract manufacturer Samsung BioLogics could pull in as much as $2 billion through an initial public offering, according to regulatory filings posted this week. The figures would position it as South Korea’s 3rd-largest IPO. BioLogics, which is 47.8% owned by Samsung Electronics (LON:BC94), this week gave new information on the planned offering, which would value the […]
Samsung to spur wearable health tech with ‘bio-processor’ chip
Samsung Electronics (LON:BC94) today launched its Bio-Processor, a health and fitness monitoring chip which processes 5 different biometric signals, hoping the chip will accelerate development of wearable health tech. The new processor is already in mass production, and is the industry’s 1st all-in-one health solution chip, according to the Japanese electronics giant. “With improvements in […]
Medtronic expands Samsung deal into neuromod
Medtronic (NYSE:MDT) said it expanded its strategic partnership with Samsung Electronics (LON:BC94) into the neuromodulation arena, looking to treat chronic pain, movement disorders, incontinence and other conditions. The announcement was made today at the North American Neuromodulation Soceity’s scientific session in Las Vegas. The combination will position Samsung to develop tools on Google‘s (NSDQ:GOOG) Android tablet […]
Samsung win FDA 510(k) for digital radiography system
Samsung Electronics (LON:BC94) subsidiary NeuroLogica said yesterday it won FDA 510(k) clearance for its GC85A digital radiography system. The newly cleared ceiling x-ray unit comes with S-Vue imaging, a wireless S-Detector, mobile system control, smart stiching and other improvements, the company said. “The Samsung GC85A represents NeuroLogica’s latest commitment to introducing user and patient-centric innovation […]
Samsung’s Bioepis considers Nasdaq IPO, seeks funding
(Reuters) – South Korean Samsung‘s (LON:BC94) Bioepis Co Ltd, a developer of generic versions of biotech drugs, said it was considering a Nasdaq IPO – a move that comes as it seeks about $1.3 billion for product development and as the Samsung Group makes a bigger push into biopharmaceuticals. Highlighting growth opportunities for its biopharmaceuticals business may […]
Diabetes: Medtronic partners with Samsung, Glooko; wins 510(k) for MiniMed Connect
Medtronic (NYSE:MDT) today announced a slew of developments from its diabetes treatment arm, including FDA clearance of its MiniMed Connect diabetes monitoring system; a partnership with Samsung Electronics (LON:BC94) to develop technology for diabetes management; and an agreement with diabetes-monitoring platform developer Glooko. The announcements were made at the American Diabetes Assn.’s annual meeting in Boston. […]
